Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Doxazosin, An Alpha-1 Adrenergic Antagonist, for Cocaine Dependence: Pilot Study

NCT00880997 is registered in ClinicalTrials.gov with Baylor College of Medicine as lead sponsor.

NCT NCT00880997
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00880997 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Doxazosin, An Alpha-1 Adrenergic Antagonist, for Cocaine Dependence: Pilot Study
Lead sponsor
Baylor College of Medicine
Phase
Phase 1
Overall status
Completed
Start date
September 30, 2009
Completion date
December 31, 2011
Enrollment
35 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cocaine dependence